Norwegian School of Veterinary Science, Department of Basic Sciences and Aquatic Medicine, Section of Aquatic Medicine and Nutrition, P.O. Box 8146 Dep, N-0033 Oslo, Norway.
Vaccine. 2012 Jun 8;30(27):4007-16. doi: 10.1016/j.vaccine.2012.04.039. Epub 2012 Apr 23.
Two strains of IPNV made by reverse genetics on the Norwegian Sp strain NVI-015 (GenBank AY379740) backbone encoding the virulent (T(217)A(221)) and avirulent (P(217)T(221)) motifs were used to prepare inactivated whole virus (IWV), nanoparticle vaccines with whole virus, Escherichia coli subunit encoding truncated VP2-TA and VP2-PT, VP2-TA and VP2-PT fusion antigens with putative translocating domains of Pseudomonas aeruginosa exotoxin, and plasmid DNA encoding segment A of the TA strain. Post challenge survival percentages (PCSP) showed that IWV vaccines conferred highest protection (PCSP=42-53) while nanoparticle, sub-unit recombinant and DNA vaccines fell short of the IWV vaccines in Atlantic salmon (Salmo salar L.) postsmolts challenged with the highly virulent Sp strain NVI-015 (TA strain) of IPNV after 560 degree days post vaccination. Antibody levels induced by these vaccines did not show antigenic differences between the virulent and avirulent motifs for vaccines made with the same antigen dose and delivery system after 8 weeks post vaccination. Our findings show that fish vaccinated with less potent vaccines comprising of nanoparticle, DNA and recombinant vaccines got infected much earlier and yielded to higher infection rates than fish vaccinated with IWV vaccines that were highly potent. Ability of the virulent (T(217)A(221)) and avirulent (P(217)T(221)) motifs to limit establishment of infection showed equal protection for vaccines made of the same antigen dose and delivery systems. Prevention of tissue damage linked to viral infection was eminent in the more potent vaccines than the less protective ones. Hence, there still remains the challenge of developing highly efficacious vaccines with the ability to eliminate the post challenge carrier state in IPNV vaccinology.
两种通过反向遗传学在挪威 Sp 株 NVI-015(GenBank AY379740)骨架上构建的 IPNV 毒株被用于制备灭活全病毒(IWV)疫苗、携带全病毒的纳米颗粒疫苗、编码截短 VP2-TA 和 VP2-PT 的大肠杆菌亚单位疫苗、携带有铜绿假单胞菌外毒素易位结构域的 VP2-TA 和 VP2-PT 融合抗原疫苗,以及编码 TA 株节段 A 的质粒 DNA 疫苗。攻毒后幸存率(PCSP)显示,IWV 疫苗提供了最高的保护(PCSP=42-53),而纳米颗粒、亚单位重组和 DNA 疫苗在大西洋鲑(Salmo salar L.)幼鲑接种高致病性 Sp 株 NVI-015(TA 株)IPNV 后 560 度日时,未能达到 IWV 疫苗的效果。在接种后 8 周,用相同抗原剂量和传递系统制备的疫苗中,诱导的抗体水平没有显示出针对具有相同抗原剂量和传递系统的疫苗的毒力和无毒力基序之间的抗原差异。我们的研究结果表明,与高效的 IWV 疫苗相比,用纳米颗粒、DNA 和重组疫苗接种的鱼更早感染,感染率更高,而用这些疫苗接种的鱼感染率更高。具有毒力(T(217)A(221))和无毒力(P(217)T(221))基序的能力限制了感染的建立,表明用相同抗原剂量和传递系统制备的疫苗具有同等的保护作用。与较少保护力的疫苗相比,在更有效的疫苗中,与病毒感染相关的组织损伤的预防更为明显。因此,在 IPNV 疫苗学中,仍然存在开发具有消除攻毒后携带状态能力的高效疫苗的挑战。